Montecatone Rehabilitation Institute S.p.A.
10
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
40.0%
4 terminated/withdrawn out of 10 trials
42.9%
-43.6% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Active tDCS Versus Sham tDCS for Upper Limb Recovery in Incomplete Tetraplegic Patients
Role: lead
intErnet-based iNterventions FOR Cardiac arrEst suRvivors
Role: collaborator
Hunova® Randomized Controlled Trial for Trunk Control Improvement in Spinal Cord Injured Patients
Role: lead
Modeling Outcome in Patients With Acquired Brain Injuries
Role: collaborator
Randomized Comparative Trial for Persistent Pain in Spinal Cord Injury: Acupuncture vs Aspecific Needle Skin Stimulation
Role: lead
Randomized Controlled Study on T-PEP Versus IPV Method for Lower Respiratory Airways Clearance in Tetraplegic Tracheotomized Spinal Cord Injured Patients
Role: lead
Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients
Role: lead
tDCS in Patients With Disorder of Consciousness Due to Severe Acquired Brain Injury
Role: lead
Locomotor Training With Exoskeleton EKSO-GT in Patients With Incomplete Motor Spinal Cord Injury in a Hospital Setting
Role: lead
Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury
Role: collaborator
All 10 trials loaded